The plunge of nearly 3% really caught people off guard. I didn't expect such a big adjustment. The previous low of 65438+February was broken again. Today, the lowest point 1727, the heart was pierced. ...
Affected by the negative decline of the Growth Enterprise Market, the stocks of the two cities fell into a general decline. Except for some excellent white horses that have gone against the trend, the theme has been adjusted almost across the board.
Specifically, due to bad news such as falling coal prices, cyclical stocks such as steel and coal were among the top losers; The blockchain sector, which soared continuously last week, also ushered in obvious differentiation. In addition, due to the sharp drop in the price of lithium batteries since the fourth quarter, the lithium battery sector has also weakened significantly.
Excluding ST stocks, there are 27 stocks with daily limit, and nearly 500 stocks with a decline of more than 5%. Today's adjustment is a bit intense. ...
In contrast, SSE 50 rose 1%, with the highest intraday increase of 1.73%, setting a new high in the past two years. The benchmark rose by 4.35%, China Merchants Bank rose by 1.36%, the intraday market value of Maotai exceeded one trillion, and the highest intraday price was 799.06 yuan.
Insurance and banks are soaring today. Taibao, Xinhua, Life Insurance, Ping An Bank and Workers and Peasants Jianzhong are as stable as ever, and they can't help but want to get on the bus. ...
I think this adjustment may be caused by the jump of funds. Small-cap stocks didn't hold back their funds and went to Baima.
I took the ticket for a long time, but I got up slowly. You know, some big funds are leveraged and have interest. The longer the time, the stronger the interest, so I gave up and turned to ride a white horse.
At present, the trend of white horse has been going on for almost a year, and the trend has been formed. Whether the market will continue in February and August this year and whether the white horse will ride the dust, we still have to be prepared.
Men don't suffer short-term losses. Changing the position may not be the answer you want most, but it may be the most correct answer now.
The above is my uncle's personal opinion, which may not be right, but if the adjustment continues, I will step back and get on the 50 th line, and I will plan to get on the bus. Baimali is still suitable for getting on the bus, such as Ping An, Agricultural Bank of China and ICBC.
Watson biological thundered on Friday.
Watson biological 65438+1October 13 released the revised announcement of 20 17 annual performance forecast. The revised performance is a loss of 533.5 million yuan to 538.5 million yuan, and the company made a profit of 70.46 million yuan in 2065438+2006. Based on this calculation, the company's performance in 20 17 will decline by 857% year-on-year.
Previously, the company's 20 17 annual performance forecast said that the net profit attributable to shareholders of listed companies in 20 17 was expected to be 30 million yuan to 5 10/00000 yuan, which was 27% to 57% lower than the same period in 20 16.
Evaporation of 500 million in two months, this performance has changed face too quickly.
The main reason was the failure of gambling, and the company assumed the liability of compensation for Daan Pharmaceutical. The amount of blood collected by Daan Pharmaceutical is far from the standard, which has caused great losses.
It stands to reason that such a big bad news in watson biological suddenly strikes, and you can directly stop the loss before the opening. However, today, you can stay calm without eating a bowl of daily limit, and the whole day's decline does not exceed 5%, which also shows that the stock has been highly controlled by the dealer.
Speaking of which, Ren Shu wants to talk about the pharmaceutical stocks that recently released the annual performance forecast.
Among the recently disclosed pharmaceutical stocks, there were 10 companies with pre-reduced and pre-lost performance last year, and 80 companies with pre-increased or pre-increased performance.
Eight companies, including Yifan Medicine, Healthy Yuan, Livzon Group, Xinhecheng, Shanghai Laishi, Xinlitai, Bikang and Kangrui Medicine, expect annual net profit of more than 6,543.80 billion yuan.
Among all the pre-increased listed companies, Berry Gene ranks first. Accumulated net profit was 230 million yuan to 260 million yuan, up by 5594.60%-6311.29% year-on-year.
201710 August, Berry Pharmaceuticals was reorganized, and berry and kang became the financial parent company, which consolidated the company's financial data, so its performance increased by 50-60 times last year.
The estimated net profit of 8 shares of Yabao Pharmaceutical, Livzon Group, Yisheng Pharmaceutical, Healthy Yuan, Yongan Pharmaceutical, Tiger Pharmaceutical, Taihe Health and Shuangcheng Pharmaceutical increased by more than 65,438+000% year-on-year.
Among them, it is estimated that the largest year-on-year increase in annual net profit is Yabao Pharmaceutical, reaching 78.8%-818%. Yabao Pharmaceutical said that the pre-increase was mainly due to the increase in sales revenue of key products and high-margin products of the company.
Livzon Group increased by 460%, Yisheng Pharmaceutical and Health Yuan increased by 375% and 373%, and Yongan Pharmaceutical increased by 185%.
In addition to its own performance growth, Livzon Group obtained 3.498 billion yuan through the transfer of 0/00% equity of its subsidiary Zhuhai Weiweixing Industrial Co., Ltd., which is also one of the factors affecting the annual report.
As the controlling shareholder of Livzon Group, the performance of Health Yuan also has certain influence.
Growth companies are mostly the same, and loss-making stocks are each miserable.
In addition to watson biological, which just said that a huge thunder broke out, Jiu 'an Medical also expects a large loss, and the changes in net profit attributable to shareholders of listed companies are -864.28% respectively? -857. 18% and-1 134.63%? -996.68%。
Despite the policy support, the performance of Jiu 'an Medical in recent years is not outstanding. From 20 14 to 20 16, the revenue of Jiu 'an Medical was 425 million yuan, 398 million yuan and 420 million yuan respectively. Net profit 10 197500 yuan, loss 1.5 104497900 yuan.
Annual reports began to be disclosed. For the tickets in hand and those that haven't started yet, everyone should look at the financial report. This is a real achievement, which is mixed with water. What information is hidden behind each data is very worth digging deeply.
Chinese yam third complex model
SSE: Neutral SSE 50: Optimistic
Shanghai and Shenzhen 300: Optimistic Growth Enterprise Market: Pessimistic
Small and medium-sized board: neutral new shares: pessimism
Today, Guizhou gas continues to go up and down, which is very demon, but this period of time has not effectively driven the whole plate of new shares, indicating that it is just a carnival of one person. Let's have a look. It's a little risky to go in and stand guard now.